UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000036943
Receipt number R000037043
Scientific Title The utility of ultrasound-guided central venous cannulation by hand-held ultrasound device
Date of disclosure of the study information 2019/06/03
Last modified on 2020/05/18 11:09:38

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The utility of ultrasound-guided central venous cannulation by hand-held ultrasound device

Acronym

Central venous cannulation by hand-held ultrasound device; non-inferiority trial

Scientific Title

The utility of ultrasound-guided central venous cannulation by hand-held ultrasound device

Scientific Title:Acronym

Central venous cannulation by hand-held ultrasound device; non-inferiority trial

Region

Japan


Condition

Condition

Patients aged 20-85 years with ASA-PS 1 or 2 who are planed to undergo general anesthesia.

Classification by specialty

Cardiology Surgery in general Gastrointestinal surgery
Hepato-biliary-pancreatic surgery Vascular surgery Chest surgery
Obstetrics and Gynecology Dermatology Urology
Anesthesiology Neurosurgery Cardiovascular surgery
Adult

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Comparison of the effectiveness and safety with central venous cannulation between hand-held and conventional ultrasound device.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Duration of the procedure from internal jugular vein puncture to confirmation of guidewire placement.

Key secondary outcomes

number of punctures, needle and guidewire visibility, and anatomic visibility.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Patients undergoing central venous cannulation by hand-held ultrasound device (Vscan Dual Probe, GE Healthcare)

Interventions/Control_2

Patients undergoing central venous cannulation by ultrasound device (EDGE,Sonosite)

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

85 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients in regular surgery with ASA-PS 1 or 2, undergoing right internal jugular vein catheter placement under general anesthesia.

Key exclusion criteria

Patients with abnormalities or infection on puncture site, abnormalities of right jugular vein and artery including thrombosis, histories of head and neck surgeries or radiation, difficulties of right internal jugular vein imaging, BMI > 35 and severe lung complications.

Target sample size

56


Research contact person

Name of lead principal investigator

1st name Kenji
Middle name
Last name YAMAMOTO

Organization

Nayoro City General Hospital

Division name

Dept. of Anesthesiology

Zip code

0968511

Address

1, minami 8 - nishi 7, Nayoro-city, Hokkaido, Japan

TEL

01654-3-3101

Email

cab55640@yahoo.co.jp


Public contact

Name of contact person

1st name Kenji
Middle name
Last name YAMAMOTO

Organization

Nayoro City General Hospital

Division name

Dept. of Anesthesiology

Zip code

0968511

Address

1, minami 8 - nishi 7, Nayoro-city, Hokkaido, Japan

TEL

01654-3-3101

Homepage URL


Email

cab55640@yahoo.co.jp


Sponsor or person

Institute

Nayoro City General Hospital

Institute

Department

Personal name



Funding Source

Organization

No funding sources.

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nayoro City General Hospital

Address

1, minami 8 - nishi 7, Nayoro-city, Hokkaido, Japan

Tel

01654-3-3101

Email

cab55640@yahoo.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

名寄市立総合病院


Other administrative information

Date of disclosure of the study information

2019 Year 06 Month 03 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

56

Results


Results date posted

2020 Year 04 Month 17 Day

Results Delayed

Delay expected

Results Delay Reason

no

Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2018 Year 05 Month 06 Day

Date of IRB

2017 Year 10 Month 05 Day

Anticipated trial start date

2018 Year 05 Month 14 Day

Last follow-up date

2019 Year 03 Month 23 Day

Date of closure to data entry

2019 Year 03 Month 31 Day

Date trial data considered complete

2019 Year 03 Month 31 Day

Date analysis concluded

2019 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2019 Year 06 Month 03 Day

Last modified on

2020 Year 05 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037043


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name